Organization
Pär Johansson
3 clinical trials
Clinical trial
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 ng/kg/Min) in Mechanically Ventilated Patients With Infectious Pulmonary Endotheliopathy - a Multicenter Randomized, Placebo-controlled, Blinded, Investigator-initiated TrialStatus: Recruiting, Estimated PCD: 2026-12-30
Clinical trial
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/ Kilo(kg)/Minute(Min)) in Patients With COVID-19 Induced Pulmonary EndotheliopathyStatus: Completed, Estimated PCD: 2021-02-23
Clinical trial
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/Kilogram(kg)/Minute(Min)) in Trauma Patients With Haemorrhagic Shock Induced Endotheliopathy.Status: Completed, Estimated PCD: 2021-11-14